Status:
COMPLETED
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Bladder Cancer
Eligibility:
All Genders
Brief Summary
The goal of this research study is to improve detection of cancer outside of the bladder through genetic testing and improved imaging.
Detailed Description
If participant agrees to take part in the study, a piece of the tumor that is removed during the biopsy will be collected for research purposes. The tissue will be sent to the laboratory for genetic t...
Eligibility Criteria
Inclusion
- 1\. Patients with biopsy proven bladder cancer of any age will be eligible for enrollment.
Exclusion
- Contraindication to pelvic MRI (metallic implants/hardware, claustrophobia)
- Participants who have previously received chemotherapy as part of multimodal therapy.
Key Trial Info
Start Date :
June 25 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 16 2019
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT02203136
Start Date
June 25 2014
End Date
May 16 2019
Last Update
May 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030